Biological Dynamics, an exosome-isolation technology and early disease detection diagnostic company, announced that it has partnered with both QURE Healthcare and Curta to explore...
Blueprint Medicines Corporation announced the submission of a supplemental new drug application to the U.S. Food and Drug Administration (FDA) for AYVAKIT® (avapritinib) for...
Calyxt, Inc., a plant-based synthetic biology company announced that it has successfully completed the first phase in its research collaboration agreement with a leading...
RVAC Medicines Pte. Ltd. (RVAC), a messenger RNA (mRNA) technology platform company incubated by CBC Group, a healthcare-dedicated asset management firm headquartered in Singapore,...
Oramed Pharmaceuticals Inc., a clinical-stage pharmaceutical company focused on the development of oral drug delivery platforms, announced additional positive data from its Phase 2...
